Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof

Inactive Publication Date: 2005-03-15
F HOFFMANN LA ROCHE & CO AG
View PDF22 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The compositions in accordance with this invention improve the activity of the cell surface active protein contained therein. It is believed that the increase in biological activity results from the formation of an ionic complex between the protein and the amphiphilic compound. Accordingly, the invention further provides a method of increasing the activity of cell surface active proteins. In addition, the invention provides solid storage forms of such proteins and uses of the composition of this invention. The compositions of this invention can be used in the same way as the proteins contained therein are used, for example in in vitro assays, diagnostic methods and as therapeutic substances.

Problems solved by technology

A disadvantage of such methods is that the high concentrations of the surface-active substances that are used have a massive influence on the cell membrane and may damage it.
However, such methods are complicated and lead to inhomogeneous products due to the chemical reaction of the coupling (cf. e.g. Ekrami, H. M. et al., FEBS Letters 371 (1995) 283-286, Pepinski, R. B. et al., J. Biol. Chem. 273 (1998) 14037-14045).

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof
  • Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

Analysis of the Activity of Different Hedgehog Formulations in a Cell Test

Induction of Alkaline Phosphatase

5000 cells of the murine mesenchymal plutipotent line C3H10T1 / 2 (ATCC CCL-226) are sown in each well of a 96-well microtiter plate. The cells are in DMEM, 2 mM glutamine, 100 IU penicillin / ml, 100 μg streptomycin / ml and 10% foetal calf serum. On the next day the medium is replaced by medium which contains human shh (0, 5 or 50 μg / ml) in different formulations (0, 0.00016, 0.00052, 0.0013, 0.0019 or 0.01% sodium deoxycholate), or the various hedgehog formulations are added directly. The test is stopped after 5 days. For this the supernatants are decanted and the cells are washed once with PBS. The cells are lysed in 50 μl 0.1% Triton® X-100 and frozen at −20° C. After thawing, 25 μl aliquots are used for protein determination and to determine the activity of alkaline phosphatase.

Protein Determination According to the Instructions of the Manufacturer Pierce:

75 μl redistilled H2O ...

example 2

Hydrophobic Ion Pair Titration of hshh (Dimer)

Recombinant human sonic hedgehog protein (dimer, 0.8 mg / ml in 50 mM Tris-Cl, pH 7.4 or in 0.1% Tween 80, 50 mM Tris-Cl, pH 7.4) is admixed with increasing concentrations of sodium deoxycholate. The absorbance at 360 nm is measured as an indicator for turbidity (formation of water-insoluble aggregates composed of ionic protein-detergent complexes). It is clear from FIG. 2 that the transition to water-insoluble aggregates occurs above ca. 0.04% Na deoxycholate. The formation of water-insoluble aggregates can be largely prevented in the presence of 0.1% Tween 80. The stated absorbances are not corrected for dilution.

example 3

Analysis of NGF formulations in a bioactivity assay: Dorsal root ganglion neuron development assay

NGF bioactivity was determined by morphometric analysis of dorsal root ganglion (DRG) neurons developing in vitro. Briefly, lumbar DRG's were dissected from E7-E8 embryonic chickens, freed from surrounding connective tissue and dissociated by triturgation through a fire polished pasteur pipette following digestion with 0.1% trypsin for 20 min at 37° C. Contaminating cells, such as fibroblasts were removed by preplating the entire cell preparation onto plastic tissue culture dishes for 2 h. Under these conditions neurons do not attach to the substrate, while fibroblasts and other non-neuronal cells adhere to the tissue culture plastic. “Clean” neurons were harvested by collecting the supernatant and plated onto poly-omithine / laminin coated plastic dishes (48 wells) at a density of 10,000 cells / well in HAM's F14 medium containing 5% FBS. A dose-response curve for NGF was titrated from app...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Temperatureaaaaaaaaaa
Temperatureaaaaaaaaaa
Fractionaaaaaaaaaa
Login to View More

Abstract

A water-soluble composition containing a complex of an ionic pharmaceutically effective interleukin, characterized in that said composition contains, in addition, an amphiphilic compound, said interleukin and said amphiphilic compound forming an ionic complex, whereby the forming of the complex does not enhance the solubility of said interleukin, is suitable for increasing the activity of the interleukin and / or for the delayed release of the interleukin.

Description

BACKGROUND OF THE INVENTIONThe use of amphiphilic compounds as a drug delivery system is well known in the state of the art (cf. U.S. Patents U.S. Pat. No. 5,650,393; U.S. Pat. No. 5,688,761; U.S. Pat. No. 5,665,328; U.S. Pat. No. 5,124,081; U.S. Pat. No. 5,109,038). Formation of complexes in the form of micelles between surface-active substances and pharmaceutical agents is also known for example for improving the transdermal and transmembrane penetration of the active agent (Tomlinson and Davis, J. Colloid. Interf., Sci. 74 (1980) 349). It is also known that pharmaceutical agents usually have better transport properties through biological membranes in their non-ionized form than in the ionized state (Cools and Jansen, J. Pharm. Pharmacol. 35 (1983) 689-691). It is also known that peptides which are present in a multiple ionized form at physiological pH values, are also not optimal for transport to the site of action (drug delivery) since charged molecules and in particular polypep...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K47/12A61K47/28A61K47/48A61KA61K9/00A61K9/08A61K38/00A61K9/107A61K38/02A61K38/04A61K38/16A61K38/17A61K38/18A61K38/20A61K38/21A61K38/22A61K38/36A61K45/00A61P43/00C07K7/00
CPCA61K9/0014A61K47/48784A61K9/0024A61K38/1703A61K47/12A61K47/24A61K47/28A61K47/48023A61K47/4803A61K47/48038A61K47/48046A61K47/48053A61K47/48123A61K47/48769A61K9/0019A61K9/19A61K47/541A61K47/54A61K47/542A61K47/543A61K47/544A61K47/554A61K47/69A61K47/6903A61P19/00A61P25/00A61P43/00A61K38/18
InventorPAPADIMITRIOU, APOLLON
OwnerF HOFFMANN LA ROCHE & CO AG